Trial Details
WITHDRAWNBasic Information
| Clinical ID | c3307 |
|---|---|
| Identifier | NCT02249078 |
| Trial Title | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: E6011|DRUG: Placebo |
Participant Information
| Sponsor | Eisai Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2014-12 |
|---|---|
| Primary Completion Date | 2016-03 |
| Completion Date | 2016-04 |